Mehow Innovative Ltd is engaged in the design, development, manufacture and sales of precision components and products for medical devices.
2010
n/a
LTM Revenue $243M
LTM EBITDA n/a
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mehow Innovative has a last 12-month revenue of $243M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Mehow Innovative achieved revenue of $184M and an EBITDA of $60.7M.
Mehow Innovative expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Mehow Innovative valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $184M | $227M | XXX | XXX | XXX |
Gross Profit | $70.4M | $83.9M | XXX | XXX | XXX |
Gross Margin | 38% | 37% | XXX | XXX | XXX |
EBITDA | $60.7M | n/a | XXX | XXX | XXX |
EBITDA Margin | 33% | NaN% | XXX | XXX | XXX |
Net Profit | $42.7M | $55.4M | XXX | XXX | XXX |
Net Margin | 23% | 24% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Mehow Innovative's stock price is CNY 25 (or $3).
Mehow Innovative has current market cap of CNY 10.3B (or $1.4B), and EV of CNY 8.5B (or $1.2B).
See Mehow Innovative trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.2B | $1.4B | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Mehow Innovative has market cap of $1.4B and EV of $1.2B.
Mehow Innovative's trades at 4.8x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Mehow Innovative's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Mehow Innovative and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.2B | XXX | XXX | XXX |
EV/Revenue | 5.2x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | 26.5x | XXX | XXX | XXX |
P/E/Growth | 1.1x | XXX | XXX | XXX |
EV/FCF | 11.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMehow Innovative's NTM/LTM revenue growth is 24%
Mehow Innovative's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Mehow Innovative's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Mehow Innovative's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Mehow Innovative and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 23% | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
Opex to Revenue | 18% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mehow Innovative acquired XXX companies to date.
Last acquisition by Mehow Innovative was XXXXXXXX, XXXXX XXXXX XXXXXX . Mehow Innovative acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Mehow Innovative founded? | Mehow Innovative was founded in 2010. |
Where is Mehow Innovative headquartered? | Mehow Innovative is headquartered in China. |
Is Mehow Innovative publicy listed? | Yes, Mehow Innovative is a public company listed on SHE. |
What is the stock symbol of Mehow Innovative? | Mehow Innovative trades under 301363 ticker. |
When did Mehow Innovative go public? | Mehow Innovative went public in 2022. |
Who are competitors of Mehow Innovative? | Similar companies to Mehow Innovative include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Mehow Innovative? | Mehow Innovative's current market cap is $1.4B |
What is the current revenue of Mehow Innovative? | Mehow Innovative's last 12-month revenue is $243M. |
What is the current EV/Revenue multiple of Mehow Innovative? | Current revenue multiple of Mehow Innovative is 4.8x. |
What is the current revenue growth of Mehow Innovative? | Mehow Innovative revenue growth between 2023 and 2024 was 23%. |
Is Mehow Innovative profitable? | Yes, Mehow Innovative is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.